A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : MARCKS / myristoylated alanine-rich C kinase substrate

[Related PubMed/MEDLINE]
Total Number of Papers: 463
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   MARCKS  (>> Co-occurring Abbreviation)
Long Form:   myristoylated alanine-rich C kinase substrate
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 MARCKS inhibition cooperates with autophagy antagonists to potentiate the effect of standard therapy against drug-resistant multiple myeloma. miR-34a, MM, MPS
2020 MARCKSL1 promotes the proliferation, migration and invasion of lung adenocarcinoma cells. EMT, MARCKSL1
2020 Mechanistic models of PLC/PKC signaling implicate phosphatidic acid as a key amplifier of chemotactic gradient sensing. DAG, PA, PDGF, PKC, PLC
2020 Multiplexed Phosphoproteomic Study of Brain in Patients with Alzheimer's Disease and Age-Matched Cognitively Healthy Controls. AD, GRM5, MS, TMT
2020 Restoration of MARCKS enhances chemosensitivity in cancer. 5-FU, ABC, CRC, FRET
2020 WNT5A-Induced Activation of the Protein Kinase C Substrate MARCKS Is Required for Melanoma Cell Invasion. PKC, rWNT5A
2019 Mal protein stabilizes luminal membrane PLC-beta3 and negatively regulates ENaC in mouse cortical collecting duct cells. ENaC, Mal, PLC
2019 MARCKS and Lung Disease. MARCKSL1
2019 MARCKS phosphorylation and amylase release in GLP-1-stimulated acini isolated from rat pancreas. GLP-1, PKA, PKC
10  2019 MARCKS protein overexpression is associated with poor prognosis in male breast cancer. IHC, MBC, OS
11  2019 Myristoylated alanine rich protein kinaseC substrate is a potential cancer prognostic factor that regulates cell migration and invasion in glioblastoma. EMT, GBM
12  2019 Myristoylated alanine-rich C-kinase substrate effector domain phosphorylation regulates the growth and radiation sensitization of glioblastoma. ED, PI3K, PKC, PTEN, ROCK
13  2019 Prognostic Value of Upregulation of Myristoylated Alanine-Rich C-Kinase Substrate in Gastric Cancer. EMT, GC, IHC, qRT-PCR
14  2019 Tackling MARCKS-PIP3 circuit attenuates fibroblast activation and fibrosis progression. alpha-SMA, IPF, MPS
15  2019 Targeting the phosphorylation site of myristoylated alanine-rich C kinase substrate alleviates symptoms in a murine model of steroid-resistant asthma. DEXA, OVA
16  2019 The myristoylated alanine-rich C kinase substrate differentially regulates kinase interacting with stathmin in vascular smooth muscle and endothelial cells and potentiates intimal hyperplasia formation. ECs, KIS, VSMC
17  2018 Carnosic acid protects mice from high-fat diet-induced NAFLD by regulating MARCKS. ALT, AST, CA, HF, NAFLD, NF-kappaB, NLRP3, PI3K, PKC, SREBP-1c
18  2018 Identification of DKK-1 as a novel mediator of statin effects in human endothelial cells. PAI-1, PTX3
19  2018 MARCKS and MARCKS-like proteins in development and regeneration. MARCKSL1, PKC
20  2018 MARCKS Is Necessary for Netrin-DCC Signaling and Corpus Callosum Formation. CC, NTN1
21  2018 MARCKS regulates neuritogenesis and interacts with a CDC42 signaling network. ---
22  2018 Overexpression of MARCKS indicates a poor prognosis of oral squamous cell carcinoma. OSCC
23  2018 Ser46-Phosphorylated MARCKS Is a Marker of Neurite Degeneration at the Pre-aggregation Stage in PD/DLB Pathology. AD, DLB, PD
24  2018 Systematic Analysis of Transcriptomic Profile of Chondrocytes in Osteoarthritic Knee Using Next-Generation Sequencing and Bioinformatics. EREG, LRRC15, OA, PDE3A, SMAD3, WNT5A
25  2018 The long noncoding RNA lncZic2 drives the self-renewal of liver tumor-initiating cells via the protein kinase C substrates MARCKS and MARCKSL1. BRG1, lncRNA, MARCKSL1, TICs, Zic2
26  2017 A spectroscopic sensing platform for MARCKS protein monolayers. ---
27  2017 Anti-factor Xa activities of zingerone with anti-platelet aggregation activity. ADP, FXa, ZGR
28  2017 ENaC activity is regulated by calpain-2 proteolysis of MARCKS proteins. ENaC
29  2017 ErbB4 cleavage by gonadotropin-releasing hormone receptor stimulation in cultured gonadotroph cells. ERK, GnRH, PKC, TACE
30  2017 Functional Diversification of the Four MARCKS Family Members in Zebrafish Neural Development. ---
31  2017 Generation and intracellular trafficking of a polysialic acid-carrying fragment of the neural cell adhesion molecule NCAM to the cell nucleus. ED, FGF, MMP2, MMP9, NO, PI3K, PKC, PLC, PLD, PSA
32  2017 Inhibition of AKT1 signaling promotes invasion and metastasis of non-small cell lung cancer cells with K-RAS or EGFR mutations. NSCLC
33  2017 MARCKS is Necessary for Oligodendrocyte Precursor Cell Maturation. OPC
34  2017 MARCKS phosphorylation is modulated by a peptide mimetic of MARCKS effector domain leading to increased radiation sensitivity in lung cancer cell lines. ED
35  2017 Mechanism of inhibition of taurolithocholate-induced retrieval of plasma membrane MRP2 by cyclic AMP and tauroursodeoxycholate. PM, TLC, TUDC
36  2017 MicroRNA-21 Limits Uptake of Listeria monocytogenes by Macrophages to Reduce the Intracellular Niche and Control Infection. BMDMs, NO, RHOB, WT
37  2017 miR‑34c‑3p acts as a tumor suppressor gene in osteosarcoma by targeting MARCKS. miR, OS
38  2017 Myristoylated alanine-rich C kinase substrate (MARCKS): a multirole signaling protein in cancers. PKC
39  2017 Novel direct factor Xa inhibitory compounds from Tenebrio molitor with anti-platelet aggregation activity. ADP, FXa
40  2017 Peptides derived from MARCKS block coagulation complex assembly on phosphatidylserine. ---
41  2017 Upregulation of MARCKS in kidney cancer and its potential as a therapeutic target. HIF
42  2016 An Inhaled Inhibitor of Myristoylated Alanine-Rich C Kinase Substrate Reverses LPS-Induced Acute Lung Injury in Mice. ALI, ARDS
43  2016 Differential interaction of beta2e with phosphoinositides: A comparative study between beta2e and MARCKS. PJ, PKC, poly-PIs
44  2016 Entamoeba histolytica Cysteine Proteinase 5 Evokes Mucin Exocytosis from Colonic Goblet Cells via alphavbeta3 Integrin. Eh, SFK
45  2016 Exocytosis of polyubiquitinated proteins in bortezomib-resistant leukemia cells: a role for MARCKS in acquired resistance to proteasome inhibitors. BTZ
46  2016 Involvement of inhibition of RhoA/Rho kinase signaling in simvastatin-induced amelioration of neuropathic pain. IR
47  2016 Involvement of myristoylated alanine-rich C kinase substrate phosphorylation and translocation in cholecystokinin-induced amylase release in rat pancreatic acini. CCK, DRMs, PKC
48  2016 MARCKS contributes to stromal cancer-associated fibroblast activation and facilitates ovarian cancer metastasis. CAFs, EOC
49  2016 MARCKS is involved in methylmercury-induced decrease in cell viability and nitric oxide production in EA.hy926 cells. NO
50  2016 MicroRNA 429 Regulates Mucin Gene Expression and Secretion in Murine Model of Colitis. DSS, ELISA, RT-PCR, UC
51  2016 Protein interacting with NIMA (never in mitosis A)-1 regulates axonal growth cone adhesion and spreading through myristoylated alanine-rich C kinase substrate isomerization. MARCKS-P, NIMA, PPIase
52  2016 Quantitative Tissue Proteomics Analysis Reveals Versican as Potential Biomarker for Early-Stage Hepatocellular Carcinoma. FBLN5, HCC, RTKs, VCAN
53  2016 Regulation of PI3K by PKC and MARCKS: Single-Molecule Analysis of a Reconstituted Signaling Pathway. PI3K, PIP3
54  2016 Synthesis and dephosphorylation of MARCKS in the late stages of megakaryocyte maturation drive proplatelet formation. DIGE, KO, MKs, PKC, PMA
55  2016 Vinorelbine and epirubicin share common features with polysialic acid and modulate neuronal and glial functions. FGFR, PSA
56  2015 beta-Adducin siRNA disruption of the spectrin-based cytoskeleton in differentiating keratinocytes prevented by calcium acting through calmodulin/epidermal growth factor receptor/cadherin pathway. EGFR
57  2015 Calmodulin and CaMKII modulate ENaC activity by regulating the association of MARCKS and the cytoskeleton with the apical membrane. CaMKII, ENaC, MLP-1
58  2015 Comprehensive phosphoproteome analysis unravels the core signaling network that initiates the earliest synapse pathology in preclinical Alzheimer's disease brain. AD
59  2015 Elevated intraocular pressure induces Rho GTPase mediated contractile signaling in the trabecular meshwork. AH, IOP, MLC, MYPT1, POAG, TM
60  2015 Elevated MARCKS phosphorylation contributes to unresponsiveness of breast cancer to paclitaxel treatment. ---
61  2015 Functional characterization of the tumor-suppressor MARCKS in colorectal cancer and its association with survival. CRCs, ED, MSS, siRNA, TRAIL
62  2015 In Vitro Neutrophil Migration Requires Protein Kinase C-Delta (delta-PKC)-Mediated Myristoylated Alanine-Rich C-Kinase Substrate (MARCKS) Phosphorylation. PKC
63  2015 MARCKS Signaling Differentially Regulates Vascular Smooth Muscle and Endothelial Cell Proliferation through a KIS-, p27kip1- Dependent Mechanism. BrdU, EC, KIS, VSMC
64  2015 MARCKS-dependent mucin clearance and lipid metabolism in ependymal cells are required for maintenance of forebrain homeostasis during aging. ECs
65  2015 Mechanism for phosphoinositide selectivity and activation of TRPV1 ion channels. ---
66  2015 miR-34c-3p inhibits cell proliferation, migration and invasion of hepatocellular carcinoma by targeting MARCKS. HCC, miR-34c-3p, qRT-PCR
67  2015 Molecular effects of lithium are partially mimicked by inositol-monophosphatase (IMPA)1 knockout mice in a brain region-dependent manner. Bax, IMPA, IMPA1, KO, Li, NPY, PI, PRDX2, RF, WT
68  2015 Myristoylated alanine-rich C kinase substrate (MARCKS) regulates the expression of proinflammatory cytokines in macrophages through activation of p38/JNK MAPK and NF-kappaB. ED, MANS
69  2015 Myristoylated Alanine-Rich Protein Kinase Substrate (MARCKS) Regulates Small GTPase Rac1 and Cdc42 Activity and Is a Critical Mediator of Vascular Smooth Muscle Cell Migration in Intimal Hyperplasia Formation. CASMCs, PDGF, VSMC
70  2015 Targeting phospho-MARCKS overcomes drug-resistance and induces antitumor activity in preclinical models of multiple myeloma. HMCLs, MM
71  2015 Targeting the effector domain of the myristoylated alanine rich C-kinase substrate enhances lung cancer radiation sensitivity. ED, NP, PI3K, RTKs, WT
72  2015 The Effector Domain of MARCKS Is a Nuclear Localization Signal that Regulates Cellular PIP2 Levels and Nuclear PIP2 Localization. DGK, WT
73  2015 X MARCKS the spot: myristoylated alanine-rich C kinase substrate in neuronal function and disease. ---
74  2014 A peptide that inhibits function of Myristoylated Alanine-Rich C Kinase Substrate (MARCKS) reduces lung cancer metastasis. ---
75  2014 Alteration in MARCKS phosphorylation and expression by methylmercury in SH-SY5Y cells and rat brain. ---
76  2014 Alterations of the myristoylated, alanine-rich C kinase substrate (MARCKS) in prefrontal cortex in schizophrenia. DLPFC, pMARCKS
77  2014 Endothelial cell adhesion to soluble vascular endothelial growth factor receptor-1 triggers a cell dynamic and angiogenic phenotype. ECs, sVEGFR-1
78  2014 MARCKS regulates membrane targeting of Rab10 vesicles to promote axon development. PPVs
79  2014 Myostatin inhibits proliferation and insulin-stimulated glucose uptake in mouse liver cells. MALAT1
80  2014 Myristoylated Alanine Rich C Kinase Substrate (MARCKS) is essential to beta2-integrin dependent responses of equine neutrophils. ---
81  2014 Myristoylated alanine-rich C kinase substrate coordinates native TRPC1 channel activation by phosphatidylinositol 4,5-bisphosphate and protein kinase C in vascular smooth muscle. PKC, TRPC1, VSMCs
82  2014 Role of MARCKS in regulated secretion from mast cells and airway goblet cells. eHMCs, WT
83  2014 Structural characterization of a neuroblast-specific phosphorylated region of MARCKS. CD, mAb 3C3, NMR
84  2014 Suppression of chemotaxis by SSeCKS via scaffolding of phosphoinositol phosphates and the recruitment of the Cdc42 GEF, Frabin, to the leading edge. DeltaSrc, MEF
85  2013 A myristoylated alanine-rich C kinase substrate-related peptide suppresses cytokine mRNA and protein expression in LPS-activated canine neutrophils. MANS
86  2013 A novel effect of MARCKS phosphorylation by activated PKC: the dephosphorylation of its serine 25 in chick neuroblasts. PMA, PP2A
87  2013 Discovery and validation of blood biomarkers for suicidality. CFG, MAP3K3, PTEN, SI
88  2013 ELF-MF transiently increases skeletal myoblast migration: possible role of calpain system. ELF, MF
89  2013 Fibroblast Migration Is Regulated by Myristoylated Alanine-Rich C-Kinase Substrate (MARCKS) Protein. PDGF-BB, PI3K, PKC, UMANS
90  2013 Functional role of the interaction between polysialic acid and myristoylated alanine-rich C kinase substrate at the plasma membrane. FRET, GFP, PSA, PSA-NCAM
91  2013 Global characterization of signalling networks associated with tamoxifen resistance in breast cancer. ---
92  2013 Low hippocampal PI(4,5)P₂ contributes to reduced cognition in old mice as a result of loss of MARCKS. PLCgamma
93  2013 MARCKS and HSP70 interactions regulate mucin secretion by human airway epithelial cells in vitro. CSP, HSP70, NHBE, PMA
94  2013 Myristoylated alanine-rich C-kinase substrate as a prognostic biomarker in human primary lung squamous cell carcinoma. SCC
95  2013 Myristoylated Alanine-Rich protein Kinase C Substrate (MARCKS) expression modulates the metastatic phenotype in human and murine colon carcinoma in vitro and in vivo. AURKB, CRC
96  2013 Protein kinase C controls vesicular transport and secretion of apolipoprotein E from primary human macrophages. APOE, HMDMs, PKC, PMA
97  2013 Protein kinase C isozymes regulate matrix metalloproteinase-1 expression and cell invasion in Helicobacter pylori infection. AP-1, MMP-1, PKC
98  2013 Sealing of transected neurites of rat B104 cells requires a diacylglycerol PKC-dependent pathway and a PKA-dependent pathway. DAG, nPKCeta, PKA, PLC, seal
99  2013 Taurolithocholate-induced MRP2 retrieval involves MARCKS phosphorylation by protein kinase Cϵ in HUH-NTCP Cells. cAMP, DN, MRP2, PM, pMARCKS, TLC
100  2013 The potential interaction of MARCKS-related peptide and diltiazem on acrolein-induced airway mucus hypersecretion in rats. BALF